SCHEMBL423106

SCHEMBL423106

CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCCC

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.75
ALDH1A1 P00352 6/20 0.73
MAPT P10636 1/20 0.73
THRB P10828 1/20 0.73
CNR1 P21554 1/20 0.73
CYP3A4 P08684 2/20 0.65
ALOX15 P16050 2/20 0.65
TSHR P16473 2/20 0.65
HSD17B10 Q99714 2/20 0.65
TDP1 Q9NUW8 2/20 0.65
F7 P08709 4/20 0.63
F3 P13726 4/20 0.63
KDM4E B2RXH2 3/20 0.63
PPARG P37231 3/20 0.63
PPARD Q03181 3/20 0.63
PPARA Q07869 3/20 0.63
FFAR1 O14842 3/20 0.63
FABP3 P05413 2/20 0.63
PTGS1 P23219 2/20 0.63
DUSP3 P51452 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23068612 1.00 MGLL (0.75) MGLLALDH1A1MAPTTHRBCNR1
SCHEMBL8982650 1.00 MGLL (0.75) MGLLALDH1A1MAPTTHRBCNR1
SCHEMBL29562070 1.00 MGLL (0.75) MGLLALDH1A1MAPTTHRBCNR1
SCHEMBL23068611 1.00 MGLL (0.75) MGLLALDH1A1MAPTTHRBCNR1
SCHEMBL8982652 1.00 MGLL (0.75) MGLLALDH1A1MAPTTHRBCNR1
Iodide SCHEMBL28774881 0.98 MGLL (0.73) MGLLALDH1A1MAPTTHRBCNR1
Methane SCHEMBL28105583 0.98 MGLL (0.73) MGLLALDH1A1MAPTTHRBCNR1
SCHEMBL3660029 0.95 MGLL (0.82) MGLLALDH1A1MAPTTHRBCNR1
SCHEMBL7639501 0.95 MGLL (0.77) MGLLALDH1A1MAPTTHRBCNR1
SCHEMBL3660027 0.95 MGLL (0.82) MGLLALDH1A1MAPTTHRBCNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 362 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025076049-A1 LIPID COMPOUNDS, LIPID NANOPARTICLES, AND PHARMACEUTICAL COMPOSITIONS BROADPHARM INC. (US) 2025-04-10 WO claimed
CN-118892519-A Poultry odor composition, poultry odor agent, and preparation methods and applications thereof 宁波三生生物科技股份有限公司 2024-11-05 CN claimed
CN-109438240-B Preparation method of stable iodized linoleate 季珉 2022-05-03 CN claimed
CN-110818564-A Method for preparing high-carbon dibasic acid ester by using unsaturated fatty acid ester 石河子大学 2020-02-21 CN claimed
CN-110463696-A It is a kind of to be suitble to fly the anti-pesticide dry suspending agent and its preparation method and application used JIANGSU ROTAM CHEMISTRY CO LTD 2019-11-19 CN claimed
EP-2736879-B2 GENERAL METHOD FOR PREPARING FATTY ACYL AMIDO BASED SURFACTANTS UNILEVER PLC A COMPANY REGISTERED IN ENGLAND AND WALES UNDER COMPANY NO 41424 OF (GB) 2019-07-03 EP claimed
CN-109438240-A A kind of preparation method of stable iodinated linoleic acid ester 季珉 2019-03-08 CN claimed
CN-108822456-A It is used to prepare the material and preparation method thereof of chliorinated polyvinyl chloride antistatic hose 上海氯碱化工股份有限公司 2018-11-16 CN claimed
CN-107325134-B A kind of sucrose-fatty esters compound and preparation method thereof and purification process 广州市禾基生物科技有限公司 2018-09-28 CN claimed
CN-107325134-A A kind of sucrose-fatty esters compound and preparation method thereof and purification process 广州市禾基生物科技有限公司 2017-11-07 CN claimed
CN-1646032-A Compositions comprising short and long chain fatty acids and methods of their use for the management of body weight PROCTER & GAMBLE (US) 2005-07-27 CN claimed
WO-2005016332-A1 COMPOSITIONS AND METHODS FOR TREATING GASTROINTESTINAL CONDITIONS THE PROCTER & GAMBLE COMPANY (US) 2005-02-24 WO claimed
US-20050032892-A1 Compositions, kits, and methods for treating gastrointestinal conditions THE PROCTER & GAMBLE COMPANY (US) 2005-02-10 US claimed
US-20030203004-A1 Compositions comprising short and long chain fatty acids and methods of their use for the management of body weight PROCTER & GAMBLE COMPANY, THE 2003-10-30 US claimed
US-6440910-B1 ETHOXYLATE COMPONENT AND A FATTY ACID ESTER COMPONENT. ECOLAB INC. 2002-08-27 US claimed
US-6180592-B1 USED FOR REMOVING ORGANIC HYDROPHOBIC SOILS, SUCH AS OILY OR GREASY SOILS, FROM LAUNDRY ITEM AND/OR FROM HARD SURFACE SUCH AS ENGINE PART AND/OR FROM SKIN; INCLUDES AN ETHOXYLATE COMPONENT AND FATTY ACID ESTER COMPONENT ECOLAB INC. 2001-01-30 US claimed
WO-2000056847-A1 HYDROPHOBIC AND PARTICULATE SOIL REMOVAL COMPOSITION ECOLAB INC. (US) 2000-09-28 WO claimed
EP-0431942-B1 Percutaneously absorbable pharmaceutical preparation containing dopamine derivative SANSHO CO (JP) 1994-03-23 EP claimed
CN-1068016-A GRAPE DRYING PROMOTER GRAPE DRYING AGENT TEST FACTOR (CN) 1993-01-20 CN claimed
EP-0431942-A2 Percutaneously absorbable pharmaceutical preparation containing dopamine derivative SANSHO CO., LTD. (JP) 1991-06-12 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030203004-A1 Compositions comprising short and long chain fatty acids and methods of their use for the management of body weight FABP2, FABP6, FABP4 MGLL 29/4885ALDH1A1 2808/4885MAPT 4499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.